Tribenzor and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tribenzor (amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil) and Pataday (olopatadine hydrochloride). Common drug interactions include dyspnoea among females.

The phase IV clinical study analyzes what interactions people have when they take Tribenzor and Pataday. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Tribenzor?

Tribenzor has active ingredients of amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 1,841 Tribenzor users. Check the latest studies of Tribenzor.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.



On Jul, 31, 2026

20 people who take Tribenzor and Pataday together, and have interactions are studied.

Tribenzor and Pataday drug interactions.

What are the common drug interactions of Tribenzor and Pataday, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Drug hypersensitivity
  4. Dry eye (lack of adequate tears)
  5. Fall
  6. Heart rate increased
  7. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  8. Suicidal ideation
  9. Upper respiratory tract infection
  10. Vaginal haemorrhage (vaginal bleeding)

male:

n/a

What are the common drug interactions of Tribenzor and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Asthenia (weakness)
  2. Cough
  3. Diarrhoea
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Hot flush (sudden feelings of heat)
  7. Influenza
  8. Lung disorder (lung disease)
  9. Night sweats (sweating in night)
  10. Pancreatitis (inflammation of pancreas)

60+:

  1. Exostosis (formation of new bone on the surface of a bone)
  2. Fatigue (feeling of tiredness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fall
  5. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  6. Vaginal haemorrhage (vaginal bleeding)
  7. Food allergy
  8. Chronic kidney disease
  9. Renal failure (kidney dysfunction)
  10. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 75.00%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 75.00%
  3. Cardiac Disorder: 3 people, 15.00%
  4. Pain: 3 people, 15.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  6. Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 2 people, 10.00%
  7. Thyroid Diseases: 2 people, 10.00%
  8. Asthma: 2 people, 10.00%
  9. Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 2 people, 10.00%
  10. Cough: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tribenzor and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tribenzor and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tribenzor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tribenzor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil and olopatadine hydrochloride (the active ingredients of Tribenzor and Pataday, respectively), and Tribenzor and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: